AI-PIA · Digital health & life sciences
AI Privacy Impact Assessment for Clinical Research Organizations
An AI-PIA for a CRO exists because AI-assisted eligibility screening, recruitment matching or risk-based monitoring now shows up in study protocols and sponsor bids before anyone has documented how it touches participant data. The trigger is usually a new AI feature entering a proposal, or a research ethics board asking a question the team cannot yet answer with evidence. We assess how the AI interacts with coded and identified trial data, and produce the documentation an REB or a sponsor bid review actually expects to see.
Reviewed by the Privacy Horizon team · Last reviewed
What you're protecting
What the AI-PIA has to examine in trial delivery
AI tools in this environment usually sit close to eligibility, recruitment or monitoring decisions, which raises the stakes of getting the data-handling picture wrong.
Eligibility screening and recruitment matching
Tools that score or rank potential participants against protocol criteria, often working from health records or registry data before a participant has formally consented to anything.
Risk-based monitoring algorithms
Statistical models flagging sites or data points for closer monitoring, which can draw on identifiable source data even when the outputs are presented at an aggregate level.
Whether the tool sees coded data or identities
The assessment has to establish plainly whether an AI system operates on key-coded data, fully identified data, or both at different stages of its pipeline.
Automated safety-signal flagging in eCOA/ePRO
Tools that automatically flag potential adverse events from patient-reported data, where an assessment error has consequences beyond privacy alone.
Regulatory map
Why AI use in trials pulls in research ethics as well as privacy law
An AI-PIA for a CRO has to satisfy two different reviewers at once — a research ethics board and, separately, the organization's own privacy obligations.
TCPS 2's identifiability categories and REB oversight
Chapter 5 requires REB oversight of safeguards for research data and distinguishes identifiability categories that an AI tool's data pipeline needs to be mapped against explicitly.
PIPEDA's accountability for automated processing
PIPEDA's accountability principle applies regardless of whether a decision is made by a person or an algorithm, so an AI tool scoring eligibility still needs a documented basis for how it uses personal information.
REB approval as the gate for new data uses
Division 5's requirement for REB approval per site means an AI feature introducing a new use of participant data generally needs that use reviewed and approved before it goes live, not after.
What goes wrong
What an AI-PIA prevents from surfacing later
The risks here tend to surface at the worst possible time — during REB review or a sponsor's bid evaluation — if they were not documented earlier.
An AI feature going live without REB awareness
A recruitment or screening tool adopted operationally before anyone flags it to the research ethics board can force a retroactive review mid-study.
Re-identification risk in a screening pipeline
An eligibility tool that combines coded trial data with an external identified dataset can recreate identifiability the coding structure was meant to prevent.
Unexplainable risk-based monitoring flags
A monitoring algorithm that cannot explain why it flagged a particular site or data point leaves the organization unable to justify a decision an inspector later questions.
A sponsor bid stalling on an undocumented AI claim
A proposal mentioning an AI-assisted capability without a supporting assessment behind it invites exactly the follow-up question that slows down bid evaluation.
Our ai-pia for clinical research organizations
What our AI-PIA covers for a CRO
An assessment built around how AI actually touches trial data, not a generic AI-governance checklist.
Data-flow mapping for the AI tool
Tracing what data the AI system receives, whether coded or identified, and where its outputs go — into a screening decision, a monitoring flag, or a report.
REB-ready documentation
An assessment written in language a research ethics board can act on directly, distinct from a general internal risk memo.
Bias and reliability review
A review of where the tool's outputs might disadvantage particular participant groups or produce unreliable eligibility or monitoring decisions.
Sponsor-facing summary
A concise version of the assessment suited to a sponsor bid review, showing the organization has already thought through the AI feature's data implications.
How the engagement runs
How the assessment runs alongside protocol development
We work with your protocol and QA teams so the assessment lands before the AI feature needs REB sign-off, not after.
Step 1
Tool and data intake
We identify what the AI tool does, what data it uses, and at what stage of screening, recruitment or monitoring it operates.
Step 2
Risk assessment
We assess identifiability risk, bias exposure and reliability concerns specific to the tool's role in the trial.
Step 3
Documentation
We produce the REB-ready assessment and, where relevant, the sponsor-facing summary for bid or qualification purposes.
Step 4
Review cadence
We set a trigger for reassessment whenever the tool, its data sources or its deployment scope changes.
What it costs
What drives AI-PIA cost for a CRO
Cost depends on how many distinct AI tools are in scope, whether the assessment needs to support an active REB submission, and whether a sponsor-facing summary is needed alongside the internal document. A single eligibility-screening tool assessed for one protocol costs less than a portfolio-wide review of risk-based monitoring across multiple studies.
Get a tailored quote once we understand which AI tools are in use or planned, and which protocol or bid timeline the assessment needs to support.
Clinical Research Organizations: AI-PIA questions, answered
In most cases, yes. If the tool uses participant or candidate data to make or influence a screening decision, it represents a new data use that generally needs REB awareness, and an AI-PIA gives the board the documentation it needs to review it properly rather than approve it blind.
It documents what data the algorithm draws on, whether that includes identified source data, and how confident the organization can be in explaining a given flag if a sponsor, site or inspector asks why a particular site was selected for closer monitoring.
It reduces certain risks but does not eliminate the assessment requirement, since coded data can often still be re-identified and the tool's decisions still affect real participants. The assessment documents that reduced risk rather than skipping the review entirely.
Typically QA and the protocol lead review it first, checking that the assessment accurately reflects how the tool will actually be used, before it goes forward as supporting documentation for REB submission.
Increasingly, yes, particularly for larger or global sponsors evaluating multiple CROs. A completed assessment signals the organization has already addressed the data question a sponsor's own review would otherwise raise later in the process.
The assessment examines both the privacy implications of the flagging process and the reliability of the flags themselves, since a false negative in automated safety-signal detection carries consequences beyond a typical privacy risk.
More for clinical research organizations
Other services for this niche
- Privacy & security for clinical research organizations — overview
- Virtual CISO
- Virtual Privacy Officer
- Penetration Testing
- Incident Response Planning
- Privacy & Security Policy Development
- Privacy & Security Training
- Vendor Security Review & Questionnaire Support
- SOC 2 Readiness
- ISO 27001 Readiness
- HIPAA Readiness
About this service
Answers & guides
- When do you need an AI Privacy Impact Assessment (AI-PIA)?
- How do you assess the privacy and security risk of an AI vendor?
- Does a small business need an AI governance framework?
- Conducting an AI PIA in Healthcare: A Practical Walkthrough
- A Right-Sized AI Governance Framework for Small & Mid-Sized Businesses
What's Protecting Your Business from the Next Threat?
Don't wait for a breach to expose your vulnerabilities. Let Privacy Horizon secure your data, ensure compliance, and build lasting trust.